Rosetta Genomics Ltd News

Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference

REHOVOT, Israel and JERSEY CITY, New Jersey, July 3 /PRNewswire-FirstCall/ — Rosetta Genomics Ltd (Nasdaq: ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today it will present Collins Stewart Fourth Annual Growth Conference on Wednesday, July 9, at 8:30 am EST at the Mandarin Oriental Hotel in New York.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNA. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications.

Contact: Media Rachel Spielman T: +1-212-583-2714 E: media@rosettagenomics.com Investors Ron Kamienchick T: +1-646-509-1893 E: investors@rosettagenomics.com

SOURCE Rosetta Genomics Ltd

Send this news item to a friend.

Print This Page